Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Atavistik Bio, Inc
Eisai Inc.
PMV Pharmaceuticals, Inc
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Eli Lilly and Company
BeOne Medicines
Bayer
Genmab
Genmab
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
Eli Lilly and Company
Eli Lilly and Company
Terremoto Biosciences Inc.
Genmab
Jazz Pharmaceuticals
Seagen Inc.
AstraZeneca
Radiopharm Theranostics, Ltd
Myeloid Therapeutics
Tizona Therapeutics, Inc
AstraZeneca
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Cogent Biosciences, Inc.
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
Adela, Inc
Radiopharm Theranostics, Ltd
Second Life Therapeutics
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Seagen Inc.
Elephas
Fusion Pharmaceuticals Inc.
Risen (Suzhou) Pharma Tech Co., Ltd.
GlaxoSmithKline
Fate Therapeutics
NextCure, Inc.
Tanabe Pharma America, Inc.
NeoTX Therapeutics Ltd.
Avenzo Therapeutics, Inc.
Volastra Therapeutics, Inc.
SystImmune Inc.